Label: BULBINUM- medulla oblongata granule
- NDC Code(s): 62106-6973-4
- Packager: Seroyal USA
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved homeopathic
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
Drug Label Information
Updated September 25, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- PURPOSE
- WARNINGS
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
- OVERDOSAGE
- INACTIVE INGREDIENT
- DOSAGE & ADMINISTRATION
- INDICATIONS & USAGE
- QUESTIONS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
BULBINUM
medulla oblongata granuleProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:62106-6973 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ORYCTOLAGUS CUNICULUS SPINAL CORD (UNII: 49SKT79UB3) (ORYCTOLAGUS CUNICULUS SPINAL CORD - UNII:49SKT79UB3) ORYCTOLAGUS CUNICULUS SPINAL CORD 3 [hp_X] Inactive Ingredients Ingredient Name Strength LACTOSE (UNII: J2B2A4N98G) SUCROSE (UNII: C151H8M554) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62106-6973-4 10 in 1 CARTON 07/22/2015 06/30/2024 1 140 in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 07/22/2015 06/30/2024 Labeler - Seroyal USA (018361118) Establishment Name Address ID/FEI Business Operations SAN’UP 401010287 manufacture(62106-6973)